RecallHawk

AMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM AND SULBACTAM SODIUM)

ISTITUTO BIO ITA SPA

Summary

FDA approved AMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM AND SULBACTAM SODIUM) by ISTITUTO BIO ITA SPA. ANDA (Generic) approval (Labeling) on 2026-03-03. INJECTABLE, INJECTION.

Details

Source

Drug Approval

External ID

ANDA065222-18

Action Date

2026-03-03

Status

Approved

Category

drug

Product Code

ANDA (Generic)

Product Description

AMPICILLIN AND SULBACTAM (generic: AMPICILLIN SODIUM AND SULBACTAM SODIUM), INJECTABLE, INJECTION. Application: ANDA065222

Context & Analysis

ISTITUTO BIO ITA SPA has 5 FDA actions in our database.

Frequently Asked Questions

How often does ISTITUTO BIO ITA SPA have FDA actions?

ISTITUTO BIO ITA SPA has 5 FDA actions in our database, including 0 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "ANDA065222-18" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions